
The Canadian giant still feels rosy on the long play.
The Canadian giant still feels rosy on the long play.
We asked some cannabis executives what their predictions are for the industry in 2022. The answers ranged from optimistic outlooks on legislation to dire thoughts with regards to the California market.
As we put 2021 in the rearview mirror, Green Market Report is looking ahead to a bright new year. We asked leaders in the industry for their predictions for the cannabis industry in 2022.
Emily Paxhia, co-founder and managing director of Poseidon Investment Management said, “2022 is going to be the start of the longest bull market this industry will have seen to date. This industry has gone through multiple phases, as an emerging industry. The business case for cannabis is now being proven to be strong growth + EBITDA and there is a lot of upsides to unlock with new markets opening on the east coast.” She also believes 2022 is going to be the year that cannabis tech finally gets the attention it deserves. She thinks the market will see more capital invested into tech platforms. Paxhia added, “Further, we are excited to see more innovation in technology around the cultivation, processing, distribution, and retailing of cannabis, not to mention the technology around human capital, as this industry will continue to be a growing and large employer in the US. The cannabis market is finally getting the TAM (Total Addressable Market) recognition it deserves from outside investors.”
“Institutional capital returns to the US plant-touching space as soon as Biden or the Treasury make positive comments, yet before a banking bill passes. This capital and a renewed analysis of fundamentals will exasperate growth for profitable operators in 2022.,” said Poseidon Managing Director Michael Boniello. Boniello wasn’t all rainbows and unicorns though. He cautioned that Canadian LPs will be desperate to penetrate the U.S. but without a clear pathway to federal legalization, their export business will not support their massive operations. He also believes that Europe will see little to no progression in an Adult Use THC market in 2022. When it comes to politics, he thinks Republicans will flip the script on President Biden and Senator Schumer as GOP members campaign in the midterms for SAFE Banking and cannabis for Veterans. “They will not be for full legalization and won’t have to be to gain cannabis-friendly voters,” said Boniello. “No federal cannabis reform occurs due to misgovernance and mismanagement by the Democratic party. Federal legalization is impossible, and Schumer will have lost the progressive wing on a standalone banking bill without significant and immediately impactful social justice reform included.”
Paxhia concluded with, “I am excited to watch GenZ as a driver of cannabis in 2022. They are a ‘cannabis native’ generation, entering the workforce with cannabis substantially legal across the US. I think they will drive growth in newer product categories such as beverage and sensibly dosed edibles. Further, I believe they will continue to grow the once maligned vape category.”
Poseidon Investment Management, LLC (“PIM”) is a registered investment advisor.
This presentation contains forward-looking statements based on PIM’s experience and expectations about the markets in which it invests and the methods by which PIM expects to invest in those markets. Those statements are sometimes indicated by words such as “expects,” “believes,” “seeks,” “may,” “intends,” “attempts,” “will” and similar expressions. Such forward-looking statements are not guarantees of future performance and are subject to many risks, uncertainties and assumptions that are difficult to predict. PIM does not undertake any obligation to revise or update any forward-looking statement for any reason.
As this momentous year winds down, Green Market Report asked various leading cannabis companies what their predictions are for the coming year.
Here is the response from RIV Capital, which is an operating and brand platform that aims to acquire, invest in, and develop U.S. cannabis companies to build the cannabis industry of tomorrow, today. RIV Capital also has a strategic relationship with The Hawthorne Collective, a subsidiary of The Scotts Miracle-Gro Company (NYSE: SMG), to which RIV Capital is the Hawthorne Collective’s preferred vehicle for investments not under the purview of other ScottsMiracle-Go subsidiaries.
Unpack the industry with the daily cannabis newsletter for business leaders.
Unpack the industry with the daily cannabis newsletter for business leaders.